Načítá se...
Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis
BACKGROUND: Immunosuppressive therapy may potentially alter the natural disease course of scleroderma. There have been reports of using mycophenolate mofetil (MMF) for the treatment of scleroderma skin disease. OBJECTIVE: To analyse the experience of using MMF for the treatment of active diffuse cut...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3828653/ https://ncbi.nlm.nih.gov/pubmed/21378404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2010.142000 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|